Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03237858 · ClinicalTrials.gov registry record · NA
Multiple Cardiac Sensors for the Management of Heart Failure
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT03237858 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 200 participants.
The verdict
NCT03237858, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The MANAGE-HF study is a multi-center, global, prospective, open label, multi-phase trial intended to evaluate the clinical efficacy of the HeartLogic heart failure diagnostic feature.
Interventions
- DEVICE HeartLogic ON
- DEVICE HeartLogic OFF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-08-30 |
| Est. Completion | 2020-07-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03237858
The ClinicalTrials.gov registry entry for NCT03237858 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HeartLogic ON is the first listed.
NCT03237858 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03237858 about?
NCT03237858 is a clinical study titled "Multiple Cardiac Sensors for the Management of Heart Failure". The MANAGE-HF study is a multi-center, global, prospective, open label, multi-phase trial intended to evaluate the clinical efficacy of the HeartLogic heart failure diagnostic feature.
What is the current status of trial NCT03237858?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2017-08-30. Estimated completion is 2020-07-21.
What interventions are being tested in trial NCT03237858?
The interventions under investigation include: HeartLogic ON (DEVICE), HeartLogic OFF (DEVICE).
Who is sponsoring clinical trial NCT03237858?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.